Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
When rickets fails to improve with standard vitamin D, the cause is usually genetic or renal rather than dietary, including X-linked hypophosphatemia and other FGF23-driven phosphate-wasting disorders, hereditary vitamin D-resistant rickets from vitamin D receptor mutations, 1-alpha-hydroxylase deficiency, renal tubular acidosis, Fanconi syndrome, and chronic kidney disease. Malabsorption from celiac disease, severe dietary calcium deficiency, and medications such as certain anticonvulsants or phosphate-binding antacids can also blunt the response. Because treatment differs sharply by cause, with phosphate and active vitamin D analogs or FGF23-targeted therapy replacing plain supplements, blood and urine testing plus growth and bone assessment guide the diagnosis, and there are several important factors to consider before assuming a supplement dose is simply too low. See below to understand more, including the warning signs that point toward each underlying condition.
Persistent bowing, bone pain, poor growth, or dental problems despite treatment deserve a clear explanation rather than a higher dose, so take a few minutes to organize your symptoms with a free, instant, online symptom check and see which possibilities fit your situation. It can help you frame the right questions, understand which tests may be relevant, and decide how urgently to bring this to a clinician.
Last reviewed for medical accuracy: 08/18/2026
Rickets is a bone-softening condition most often caused by vitamin D deficiency. However, when a child’s symptoms don’t improve despite adequate vitamin D intake, we consider “vitamin D resistant rickets.” This term covers a group of rare conditions that interfere with bone mineralization in ways other than simple vitamin D lack. Early recognition helps families get the right tests and treatments without unnecessary delays.
Children with vitamin D resistant rickets often show:
Unlike classic rickets, lab tests may reveal normal or high vitamin D levels. Instead, these forms involve issues with phosphate handling or vitamin D metabolism at the cellular level.
X-Linked Hypophosphatemic Rickets (XLH)
Autosomal Dominant Hypophosphatemic Rickets (ADHR)
Autosomal Recessive Hypophosphatemic Rickets (ARHR)
Hereditary Vitamin D–Resistant Rickets (HVDRR)
Tumor-Induced Osteomalacia
A thorough workup differentiates vitamin D resistant rickets from other conditions:
Clinical Examination
Blood Tests
Urine Tests
Genetic Testing
Imaging
Management varies with the underlying cause. Goals are to correct biochemical imbalances, improve bone strength, and promote normal growth.
Oral Phosphate Supplements
Active Vitamin D (Calcitriol or Alfacalcidol)
Burosumab (Anti-FGF23 Antibody)
High-Dose Calcitriol
Oral Calcium Supplements
Dietary Adjustments
Balanced Diet
Safe Sun Exposure
Physical Therapy
Orthopedic Care
If you notice persistent bone pain, delayed growth, or leg bowing despite vitamin D supplements, consider further evaluation. You might start with a:
free, online symptom check, using the doctor approved Ubie Symptom Checker
This tool can help you decide if a specialist visit is warranted. Always speak to a doctor about any serious or life-threatening concerns. Early diagnosis of vitamin D resistant rickets allows for timely treatment, which can improve growth outcomes and quality of life.
Speak to a doctor if you or your child show worrisome signs—timely care makes a significant difference.
(References)
* Velásquez-Jones L, Dorantes-Alvarez L, Ajuria ML. [Vitamin-D-resistant hypophosphatemic rickets]. Bol Med Hosp Infant Mex. 1984 Oct;41(10):561-8. PMID: 6095879.
* Baroncelli GI, Toschi B, Bertelloni S. Hypophosphatemic rickets. Curr Opin Endocrinol Diabetes Obes. 2012 Dec;19(6):460-7. doi: 10.1097/MED.0b013e328358be97. PMID: 23108197.
* Bitzan M, Goodyer PR. Hypophosphatemic Rickets. Pediatr Clin North Am. 2019 Feb;66(1):179-207. doi: 10.1016/j.pcl.2018.09.004. PMID: 30454743.
* Haffner D, Emma F, Eastwood DM, Biosse Duplan M, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5. PMID: 31068690; PMCID: PMC7136170.
* Ackah SA, Imel EA. Approach to Hypophosphatemic Rickets. J Clin Endocrinol Metab. 2022 Dec 17;108(1):209-220. doi: 10.1210/clinem/dgac488. PMID: 35981346; PMCID: PMC9759174.
* Miller WL, Imel EA. Rickets, Vitamin D, and Ca/P Metabolism. Horm Res Paediatr. 2022;95(6):579-592. doi: 10.1159/000527011. Epub 2022 Nov 29. PMID: 36446330.
* Chinoy A, Padidela R. Refractory Rickets. Indian J Pediatr. 2023 Jun;90(6):574-581. doi: 10.1007/s12098-023-04538-4. Epub 2023 Apr 19. PMID: 37074534; PMCID: PMC10212799.
* Ito N, Hidaka N, Kato H. The pathophysiology of hypophosphatemia. Best Pract Res Clin Endocrinol Metab. 2024 Mar;38(2):101851. doi: 10.1016/j.beem.2023.101851. Epub 2023 Nov 30. PMID: 38087658.
* Haffner D, Emma F, Seefried L, Högler W, Javaid KM, Bockenhauer D, Bacchetta J, Eastwood D, Biosse Duplan M, Schnabel D, Wicart P, Ariceta G, Levtchenko E, Harvengt P, Kirchhoff M, Gardiner O, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenický P, Rejnmark L, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2025 May;21(5):330-354. doi: 10.1038/s41581-024-00926-x. Epub 2025 Jan 15. PMID: 39814982.
* Ali DS, Carpenter TO, Imel EA, Ward LM, Appelman-Dijkstra NM, Chaussain C, Jan de Beur SM, Florenzano P, Abu Alrob H, Aldabagh R, Alexander RT, Alsarraf F, Beck-Nielsen SS, Biosse-Duplan M, Crowley RK, Dandurand K, Filler G, Friedlander L, Fukumoto S, Gagnon C, Goodyer P, Grasemann C, Grimbly C, Hussein S, Javaid MK, Khan S, Khan A, Lehman A, Lems WF, Lewiecki EM, McDonnell C, Mirza RD, Morgante E, Morrison A, Portale AA, Rao C, Rhee Y, Rush ET, Siggelkow H, Tetradis S, Tosi L, Guyatt G, Brandi ML, Khan AA. X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline. J Clin Endocrinol Metab. 2025 Jun 17;110(7):2055-2070. doi: 10.1210/clinem/dgaf093. PMID: 39960858; PMCID: PMC12187519.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.